SCHEMBL3961933

SCHEMBL3961933

O=c1[nH]c2nccnc2[nH]1.O=c1[nH]c2nccnc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GDA Q9Y2T3 2/20 0.44
ACHE P22303 1/20 0.44
GSK3A P49840 3/20 0.41
GSK3B P49841 3/20 0.41
CDK5 Q00535 3/20 0.41
TYRO3 Q06418 2/20 0.41
DYRK1B Q9Y463 2/20 0.41
AURKA O14965 2/20 0.41
PRKD3 O94806 2/20 0.41
MAP4K4 O95819 2/20 0.41
RET P07949 2/20 0.41
PIM1 P11309 2/20 0.41
KDR P35968 2/20 0.41
RPS6KA3 P51812 2/20 0.41
MAP4K2 Q12851 2/20 0.41
AURKB Q96GD4 2/20 0.41
CLK4 Q9HAZ1 2/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PAK4 O96013 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL340668 1.00 GDA (0.44) GDAACHEGSK3AGSK3BCDK5
SCHEMBL30572345 1.00 GDA (0.44) GDAACHEGSK3AGSK3BCDK5
Hydrochloric Acid SCHEMBL3957661 0.97 GDA (0.43) GDAACHEGSK3AGSK3BCDK5
Trifluoroacetic Acid SCHEMBL3954861 0.80 BRAF (0.33) GDAACHEGSK3AGSK3BPDE3B
SCHEMBL932546 0.80 KDM4E (0.46) GDAACHEGSK3AGSK3BCDK5
SCHEMBL29545868 0.80 KDM4E (0.46) GDAACHEGSK3AGSK3BCDK5
Hydrochloric Acid SCHEMBL28868510 0.78 KDM4E (0.44) GDAACHEGSK3AGSK3BCDK5
Water SCHEMBL6479622 0.78 KDM4E (0.44) GDAACHEGSK3AGSK3BCDK5
Hydrochloric Acid SCHEMBL30431695 0.78 KDM4E (0.44) GDAACHEGSK3AGSK3BCDK5
SCHEMBL5438576 0.77 KDM4E (0.40) GDAACHEGSK3AGSK3BCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP claimed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO claimed